Cytomegalovirus Diagnostics Market: By Test (Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), By Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End-user (Hospitals, Diagnostic Centers, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2022 and is poised to grow at a significant CAGR of 6.1% from 2023-29. Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease. Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.  

The Cytomegalovirus Diagnostics Market Key Developments:
  • In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome.
  • In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

Global Cytomegalovirus Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Cytomegalovirus Diagnostics Market Segmentation

By Test Type
  • Serology, Cell culture,
  • Antigenemia assay,
  • Polymerase Chain Reaction Amplification,
  • Immunohistochemistry,
  • Nucleic acid sequence-based amplification (NASBA),
  • Hybrid capture assay
By Application
  • Retinitis,
  • Pneumonia,
  • Gastrointestinal Ulcers,
  • Encephalitis,
  • Others
By End-user
  • Hospitals,
  • Diagnostic Centers,
  • Others

Frequently Asked Questions

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2022, growing at a CAGR of 6.1% during the forecast period 2023-29.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2.Global Cytomegalovirus Diagnostics Market Introduction 
2.1.Global Cytomegalovirus Diagnostics Market  - Taxonomy
2.2.Global Cytomegalovirus Diagnostics Market  - Definitions
2.2.1.Test Type
2.2.2. Application
2.2.3. End-user
2.2.4.Region
3.Global Cytomegalovirus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cytomegalovirus Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cytomegalovirus Diagnostics Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Serology, Cell culture,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Antigenemia assay,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Polymerase Chain Reaction Amplification,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Immunohistochemistry,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Nucleic acid sequence-based amplification (NASBA),
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Hybrid capture assay
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Cytomegalovirus Diagnostics Market  By  Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Retinitis,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Pneumonia,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Gastrointestinal Ulcers,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Encephalitis,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Cytomegalovirus Diagnostics Market  By  End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Centers,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Cytomegalovirus Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Cytomegalovirus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Serology, Cell culture,
9.1.2.Antigenemia assay,
9.1.3.Polymerase Chain Reaction Amplification,
9.1.4.Immunohistochemistry,
9.1.5.Nucleic acid sequence-based amplification (NASBA),
9.1.6.Hybrid capture assay
9.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Retinitis,
9.2.2.Pneumonia,
9.2.3.Gastrointestinal Ulcers,
9.2.4.Encephalitis,
9.2.5.Others
9.3.   End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals,
9.3.2.Diagnostic Centers,
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Cytomegalovirus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Serology, Cell culture,
10.1.2.Antigenemia assay,
10.1.3.Polymerase Chain Reaction Amplification,
10.1.4.Immunohistochemistry,
10.1.5.Nucleic acid sequence-based amplification (NASBA),
10.1.6.Hybrid capture assay
10.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Retinitis,
10.2.2.Pneumonia,
10.2.3.Gastrointestinal Ulcers,
10.2.4.Encephalitis,
10.2.5.Others
10.3.   End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals,
10.3.2.Diagnostic Centers,
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Cytomegalovirus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Serology, Cell culture,
11.1.2.Antigenemia assay,
11.1.3.Polymerase Chain Reaction Amplification,
11.1.4.Immunohistochemistry,
11.1.5.Nucleic acid sequence-based amplification (NASBA),
11.1.6.Hybrid capture assay
11.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Retinitis,
11.2.2.Pneumonia,
11.2.3.Gastrointestinal Ulcers,
11.2.4.Encephalitis,
11.2.5.Others
11.3.   End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals,
11.3.2.Diagnostic Centers,
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Cytomegalovirus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Serology, Cell culture,
12.1.2.Antigenemia assay,
12.1.3.Polymerase Chain Reaction Amplification,
12.1.4.Immunohistochemistry,
12.1.5.Nucleic acid sequence-based amplification (NASBA),
12.1.6.Hybrid capture assay
12.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Retinitis,
12.2.2.Pneumonia,
12.2.3.Gastrointestinal Ulcers,
12.2.4.Encephalitis,
12.2.5.Others
12.3.   End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals,
12.3.2.Diagnostic Centers,
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Cytomegalovirus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Serology, Cell culture,
13.1.2.Antigenemia assay,
13.1.3.Polymerase Chain Reaction Amplification,
13.1.4.Immunohistochemistry,
13.1.5.Nucleic acid sequence-based amplification (NASBA),
13.1.6.Hybrid capture assay
13.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Retinitis,
13.2.2.Pneumonia,
13.2.3.Gastrointestinal Ulcers,
13.2.4.Encephalitis,
13.2.5.Others
13.3.   End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals,
13.3.2.Diagnostic Centers,
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Cell Medical Ltd. (U.K.)
14.2.2.Merck & Co. Inc. (U.S.)
14.2.3.Chimerix, Inc. (U.S.)
14.2.4.Abbott Laboratories (U.S.)
14.2.5.Affymetrix, Inc. (U.S.)
14.2.6.Becton, Dickinson and Company (U.S.)
14.2.7.Bio-Rad Laboratories, Inc. (U.S.)
14.2.8.F. Hoffmann-La Roche Ltd.( Switzerland)
14.2.9.Johnson and Johnson Services Inc.,(U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Cell Medical Ltd. (U.K.)
  • Merck & Co. Inc. (U.S.)
  • Chimerix, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Affymetrix, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd.( Switzerland)
  • Johnson and Johnson Services Inc.,(U.S.)